SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrol

Biochemical and Biophysical Research Communications

Volumn 393, Issue 1, 2010, Pages 66-72

  Arunachalam, Gnanapragasam ^a   Yao, Hongwei ^a   Sundar, Isaac K ^a   Caito, Samuel ^a   Rahman, Irfan ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cigarette smoke; Endothelial dysfunction; eNOS; Oxidants; SIRT1

Indexed keywords

CIGARETTE SMOKE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; RESVERATROL; SIRTUIN 1; SPLITOMICIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL FUNCTION; DOWN REGULATION; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN;

ACETYLATION; ANTIOXIDANTS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; HYDROGEN PEROXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; SERINE; SIRTUIN 1; SMOKE; STILBENES; TOBACCO;

EID: 77249158771     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.01.080     Document Type: Article

References (32)

1. Endemann D.H., and Schiffrin E.L. Endothelial dysfunction. J. Am. Soc. Nephrol. 15 (2004) 1983-1992
2. Ambrose J.A., and Barua R.S. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J. Am. Coll. Cardiol. 43 (2004) 1731-1737
3. Le Brocq M., Leslie S.J., Milliken P., and Megson I.L. Endothelial dysfunction: from molecular mechanisms to measurement. Antioxid. Redox Signal. 10 (2008) 1631-1674
4. Raij L., DeMaster E.G., and Jaimes E.A. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J. Hypertens 19 (2001) 891-897
5. Su Y., Cao W., Han Z., and Block E.R. Cigarette smoke extract inhibits angiogenesis of pulmonary artery endothelial cells: the role of calpain. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L794-800
6. Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., Pepke-Zaba J., Cremona G., Butt A.Y., Large S.R., Wells F.C., and Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324 (1991) 1539-1547
7. Edirisinghe I., Yang S.R., Yao H., Rajendrasozhan S., Caito S., Adenuga D., Wong C., Rahman A., Phipps R.P., Jin Z.G., and Rahman I. VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J. 22 (2008) 2297-2310
8. Edirisinghe I., Arunachalam G., Wong C., Yao H., Rahman A., Phipps R.P., Jin Z.G., and Rahman I. Cigarette smoke-induced oxidative/nitrosative stress impairs vegf- and fluid shear stress-mediated signaling in endothelial cells. Antioxid. Redox Signal. (2009) 10.1089/ars.2009.2874
9. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., and Tainsky M.A. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell Biol. 23 (2003) 3173-3185
10. Tissenbaum H.A., and Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410 (2001) 227-230
11. Ota H., Akishita M., Eto M., Iijima K., Kaneki M., and Ouchi Y. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J. Mol. Cell Cardiol. 43 (2007) 571-579
12. Ota H., Eto M., Kano M.R., Ogawa S., Iijima K., Akishita M., and Ouchi Y. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1634-1639
13. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., Vasa-Nicotera M., Ippoliti A., Novelli G., Melino G., Lauro R., and Federici M. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 120 (2009) 1524-1532
14. Zhang Q.J., Wang Z., Chen H.Z., Zhou S., Zheng W., Liu G., Wei Y.S., Cai H., Liu D.P., and Liang C.C. Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc. Res. 80 (2008) 191-199
15. Csiszar A., Labinskyy N., Jimenez R., Pinto J.T., Ballabh P., Losonczy G., Pearson K.J., de Cabo R., and Ungvari Z. Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech. Ageing Dev. 130 (2009) 518-527
16. Sasaki T., Maier B., Koclega K.D., Chruszcz M., Gluba W., Stukenberg P.T., Minor W., and Scrable H. Phosphorylation regulates SIRT1 function. PLoS One 3 (2008) e4020
17. Zschoernig B., and Mahlknecht U. Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. Biochem. Biophys. Res. Commun. 381 (2009) 372-377
18. Csiszar A., Labinskyy N., Podlutsky A., Kaminski P.M., Wolin M.S., Zhang C., Mukhopadhyay P., Pacher P., Hu F., de Cabo R., Ballabh P., and Ungvari Z. Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H2721-2735
19. Yang S.R., Wright J., Bauter M., Seweryniak K., Kode A., and Rahman I. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L567-576
20. Rajendrasozhan S., Yang S.R., Kinnula V.L., and Rahman I. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177 (2008) 861-870
21. Nakamaru Y., Vuppusetty C., Wada H., Milne J.C., Ito M., Rossios C., Elliot M., Hogg J., Kharitonov S., Goto H., Bemis J.E., Elliott P., Barnes P.J., and Ito K. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. Faseb J. 23 (2009) 2810-2819
22. S.W. Caito, S. Cook, S.-R. Yang, S. Rajendrasozhan, I. Rahman, Sirtuin, an oxidant sensitive deacetylase, is posttranslationally modified and degraded by the proteasome in response to cigarette smoke in lung epithelial cells, FASEB J. (2008) 22 (Abstract 747.1).
23. Grimsrud P.A., Xie H., Griffin T.J., and Bernlohr D.A. Oxidative stress and covalent modification of protein with bioactive aldehydes. J. Biol. Chem. 283 (2008) 21837-21841
24. Ford J., Ahmed S., Allison S., Jiang M., and Milner J. JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 7 (2008) 3091-3097
25. Farout L., and Friguet B. Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid. Redox. Signal. 8 (2006) 205-216
26. Hong E.H., Lee S.J., Kim J.S., Lee K.H., Um H.D., Kim J.H., Kim S.J., Kim J.I., and Hwang S.G. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J. Biol. Chem. 285 (2010) 1283-1295
27. Braam B., and Verhaar M.C. Understanding eNOS for pharmacological modulation of endothelial function: a translational view. Curr. Pharm. Des. 13 (2007) 1727-1740
28. Barbera J.A., Peinado V.I., Santos S., Ramirez J., Roca J., and Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am. J. Respir. Crit. Care Med. 164 (2001) 709-713
29. Potente M., Ghaeni L., Baldessari D., Mostoslavsky R., Rossig L., Dequiedt F., Haendeler J., Mione M., Dejana E., Alt F.W., Zeiher A.M., and Dimmeler S. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. 21 (2007) 2644-2658
30. Mattagajasingh I., Kim C.S., Naqvi A., Yamamori T., Hoffman T.A., Jung S.B., DeRicco J., Kasuno K., and Irani K. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 104 (2007) 14855-14860
31. Ungvari Z., Labinskyy N., Mukhopadhyay P., Pinto J.T., Bagi Z., Ballabh P., Zhang C., Pacher P., and Csiszar A. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297 (2009) H1876-1881
32. Xu Y., Buikema H., van Gilst W.H., and Henning R.H. Caveolae and endothelial dysfunction: filling the caves in cardiovascular disease. Eur. J. Pharmacol. 585 (2008) 256-260